Cui‐Tao Lu
Impact in
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
Papers in
- Biomaterials 27
- Nanoparticle-Based Drug Delivery 18
- Electrospun Nanofibers in Biomedical Applications 8
-
- Advanced Drug Delivery Systems 10
Cui‐Tao Lu
71 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 122
- Pharmaceutical Science 370
- Biomaterials 780
- Molecular Medicine 130
- Biomedical Engineering 871
- Cellular and Molecular Neuroscience 264
Countries citing papers authored by Cui‐Tao Lu
This map shows the geographic impact of Cui‐Tao Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cui‐Tao Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cui‐Tao Lu more than expected).
Fields of papers citing papers by Cui‐Tao Lu
This network shows the impact of papers produced by Cui‐Tao Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cui‐Tao Lu. The network helps show where Cui‐Tao Lu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Cui‐Tao Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2022 | 19 | |
| 3 | 2022 | 24 | |
| 4 | 2020 | 14 | |
| 5 | 2017 | 30 | |
| 6 | 2017 | 55 | |
| 7 | 2017 | 22 | |
| 8 | 2016 | 85 | |
| 9 | 2016 | 43 | |
| 10 | 2016 | 29 | |
| 11 | 2016 | 61 | |
| 12 | 2016 | 42 | |
| 13 | 2015 | 13 | |
| 14 | 2013 | 34 | |
| 15 | 2013 | 7 | |
| 16 | 2012 | 22 | |
| 17 | 2012 | 6 | |
| 18 | 2011 | 4 | |
| 19 | 2011 | 3 | |
| 20 | 2008 | 17 |
About Cui‐Tao Lu
Cui‐Tao Lu is a scholar working on Biomaterials, Pharmaceutical Science, Horticulture, Biomedical Engineering and Cellular and Molecular Neuroscience, having authored 71 papers that have together received 2.3k indexed citations. Recurring topics across this work include Ultrasound and Hyperthermia Applications (29 papers), Nanoparticle-Based Drug Delivery (18 papers), RNA Interference and Gene Delivery (11 papers), Ultrasound and Cavitation Phenomena (11 papers), Advanced Drug Delivery Systems (10 papers), Photoacoustic and Ultrasonic Imaging (8 papers), Electrospun Nanofibers in Biomedical Applications (8 papers) and Nanoplatforms for cancer theranostics (6 papers). The work is most often cited by research in Pharmaceutical Science (370 citations), Biomaterials (780 citations), Molecular Medicine (130 citations), Biomedical Engineering (871 citations) and Cellular and Molecular Neuroscience (264 citations). Cui‐Tao Lu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Ying‐Zheng Zhao, Ho Lun Wong, Xinqiao Tian, Helin Xu, Jian Xiao, Jun Cai, Kaili Mao, Furong Tian, Xiaokun Li and Lei Peng. Their work appears in journals such as International Journal of Nanomedicine, Journal of drug targeting, Journal of Controlled Release, International Journal of Pharmaceutics and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.